Pfizer Outbids Novo Nordisk in Fierce Takeover Battle In a major strategic move to re-enter the booming obesity drug market, Pfizer Inc. has agreed to acquire Metsera Inc., a next-generation weight-loss drug developer, in a deal valued at $10 billion. The acquisition follows a competitive bidding war with rival pharmaceutical giant Novo Nordisk A/S, which … Continue reading Pfizer to Acquire Weight-Loss Drug Startup Metsera in $10 Billion Deal